БИОМАРКЕРЫ КРОВИ И СПИННОМОЗГОВОЙ ЖИДКОСТИ В ДИАГНОСТИКЕ И ПРОГНОЗИРОВАНИИ ИСХОДОВ НЕТРАВМАТИЧЕСКОГО ВНУТРИМОЗГОВОГО КРОВОИЗЛИЯНИЯ
https://doi.org/10.51523/2708-6011.2016-13-1-1
Аннотация
В обзоре представлены основные наиболее перспективные биомаркеры внутримозгового кровоизлияния (ВМК) крови и спинномозговой жидкости (СМЖ). Описана их потенциальная роль в диагностике, лечении и прогнозировании нетравматического ВМК
Список литературы
1. Henley, S. Biomarkers for neurodegenerative diseases / S. Henley, G. Bates, S. Tabrizi // Curr. Opin. Neurol. - 2005. - Vol. 18. - P. 698-705.
2. Tuntiyatorn, L. Identification of stroke mimics among clinically diagnosed acute strokes // L. Tuntiyatorn, P. Saksornchai, S. Tunlayade-chanont // J. Med. Assoс. Thai. - 2013. - Vol. 96. - P.1191-1198.
3. Bettermann, K. Biomarkers for stroke: in search of fingerprints / K. Bettermann // J. Stroke Cerebrovasc. Dis. - 2011. - Vol. 20. - P. 173-176.
4. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke / F. Dvorak [et al.] // Cerebrovasc. Dis. - 2009. - Vol. 27. - P. 173-176.
5. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway / J. Montaner [et al.] // Proteomics. - 2009. - Vol. 75. - P. 4785-4765.
6. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke / L. Allard [et al.] // Proteomics. - 2009. - Vol. 4. - P. 2242-2251.
7. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage / S. Moritz [et al.]. // J. Neurosurg. Anesthesiol. - 2010. - Vol. 22. - P. 21-23.
8. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern / A. Petzold [et al.] // Brain Res. Bull. - 2003. - Vol. 61(3). - P. 281-285.
9. Plasma S100B level after acute spontaneous intracerebral hemorrhage / P. Delgado [et al.] // Stroke. - 2006. - Vol. 37(11). - P. 2837-2839
10. Identification of Novel Biomarkers of Brain Damage in Patients with Hemorrhagic Stroke by Integrating Bioinformatics and Mass Spectrometry-Based Proteomics / E. Martínez-Morillo [et al.] // J. Proteome Res. - 2014. - Vol. 14. - P. 969-981.
11. Axonal pathology in subarachnoid and intracerebral hemorrhage / A. Petzold [et al.] // J. Neurotrauma. - 2005. - Vol. 22(3). - P. 407-411.
12. Plasma beta-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke / M. Hernandez-Guillamon [et al.] // Neurodegener. Dis. - 2012. - Vol. 10. - P. 320-323.
13. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage / S. Abilleira [et al.] // J. Neurosurg. - 2003. - Vol. 99. - P. 65-70.
14. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage / Y. Silva [et al.] // Stroke. - 2005. - Vol. 36. - P. 86-92.
15. Sviri, G. Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury / G. Sviri, J. Soustiel, M. Zaaroor // Acta Neurochir (Wein). - 2006. - Vol. 148. - P. 529-533.
16. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke / M. Hernandez-Guillamon [et al.] // Cerebrovasc. Dis. - 2012. - Vol. 33. - P. 55-63.
17. Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage / P. Delgado [et al.] // Stroke. - 2008. - Vol. 39. - P. 1730-1734.
18. S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. M. James [et al.] // Biomarkers. - 2009. - Vol. 14. - P. 388-394.
19. Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study / S. Lee [et al.] // Diabetologia. - 2010. - Vol. 53. - P. 429-434.
20. Molecular signatures of brain injury after intracerebral hemorrhage / J. Castillo [et al.] // Neurology. - 2002. - Vol. 58. - P. 624-629.
21. Molecular biomarker of inflammatory response is associated with rebleeding in spontaneous intracerebral hemorrhage / K. Wang [et al.] // Eur. Neurol. - 2011. - Vol. 66. - P. 322-327.
22. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score / M. Di Napoli [et al.] // Eur. Neurol. - 2012. - Vol. 5. - P. 52-57.
23. Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage / D. Rodriguez-Luna [et al.] // Stroke. - 2011. - Vol. 42. - P. 2447-2452.
24. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage / T. Steiner [et al.] // Int. J. Stroke. - 2014. - Vol. 9. - P. 840-855.
25. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association / L. B. Morgenstern [et al.] // Stroke. - 2010. - Vol. 41. - P. 2108-2129.
Рецензия
Для цитирования:
Тименова С.В. БИОМАРКЕРЫ КРОВИ И СПИННОМОЗГОВОЙ ЖИДКОСТИ В ДИАГНОСТИКЕ И ПРОГНОЗИРОВАНИИ ИСХОДОВ НЕТРАВМАТИЧЕСКОГО ВНУТРИМОЗГОВОГО КРОВОИЗЛИЯНИЯ. Проблемы здоровья и экологии. 2016;(1):4-7. https://doi.org/10.51523/2708-6011.2016-13-1-1
For citation:
Timenova S.V. BIOMARKERS OF THE BLOOD AND CEREBROSPINAL FLUID IN THE DIAGNOSIS AND PROGNOSIS OF NON-TRAUMATIC INTRACEREBRAL HEMORRHAGE. Health and Ecology Issues. 2016;(1):4-7. (In Russ.) https://doi.org/10.51523/2708-6011.2016-13-1-1
Просмотров: 331
Послать статью по эл. почте 